Huafeng Li - Search Results

Year	Number of Results
2004	1
2007	1
2008	1
2009	1
2010	3
2011	4
2012	2
2013	2
2014	4
2015	4
2016	3
2017	7
2018	9
2019	14
2020	11
2021	17
2022	18
2023	17
2024	9

1

Radiotherapy combined with immune checkpoint inhibitors in locally advanced/metastatic esophageal squamous cell carcinoma: clinical trials, efficacy and future directions.

Jiang M, Hu Y, Lin G, Chen C, Li H. Jiang M, et al. Among authors: li h. Front Immunol. 2023 May 30;14:1177085. doi: 10.3389/fimmu.2023.1177085. eCollection 2023. Front Immunol. 2023. PMID: 37325652 Free PMC article. Review.

2

Reply by Authors.

Zhang H, Zhao G, Feng G, Han H, Li H, Xiao K, Song Y, Cui J. Zhang H, et al. Among authors: li h. J Urol. 2020 Dec;204(6):1347-1348. doi: 10.1097/JU.0000000000001300.03. Epub 2020 Sep 30. J Urol. 2020. PMID: 32993449 No abstract available.

3

Advances in the Application of Photothermal Composite Scaffolds for Osteosarcoma Ablation and Bone Regeneration.

Chen X, Yang L, Wu Y, Wang L, Li H. Chen X, et al. Among authors: li h. ACS Omega. 2023 Nov 28;8(49):46362-46375. doi: 10.1021/acsomega.3c06944. eCollection 2023 Dec 12. ACS Omega. 2023. PMID: 38107965 Free PMC article. Review.

4

Early versus delayed oral feeding for patients after cesarean.

Guo J, Long S, Li H, Luo J, Han D, He T. Guo J, et al. Among authors: li h. Int J Gynaecol Obstet. 2015 Feb;128(2):100-5. doi: 10.1016/j.ijgo.2014.07.039. Epub 2014 Oct 22. Int J Gynaecol Obstet. 2015. PMID: 25457588 Review.

5

Relapsing epidemic typhus (Brill-Zinsser disease) in China.

Lu M, Chen S, Li H, Wang W, Li K. Lu M, et al. Among authors: li h. J Infect. 2024 Mar 30;88(5):106152. doi: 10.1016/j.jinf.2024.106152. Online ahead of print. J Infect. 2024. PMID: 38561066 Free article. No abstract available.

6

Integrative analysis of potential diagnostic markers and therapeutic targets for glomerulus-associated diabetic nephropathy based on cellular senescence.

Sun D, Wei S, Wang D, Zeng M, Mo Y, Li H, Liang C, Li L, Zhang JW, Wang L. Sun D, et al. Among authors: li h. Front Immunol. 2024 Jan 8;14:1328757. doi: 10.3389/fimmu.2023.1328757. eCollection 2023. Front Immunol. 2024. PMID: 38390397 Free PMC article.

7

μ-Actetato-1:2κO:O'-tribromido-2κBr-(5,5,7,12,12,14-hexa-methyl-1,4,8,11-tetra-aza-cyclo-tetra-deca-1,7-diene-1κN)dizinc(II).

Li H, Shi F, Rong R. Li H, et al. Acta Crystallogr Sect E Struct Rep Online. 2010 Sep 30;66(Pt 10):m1338. doi: 10.1107/S1600536810033702. Acta Crystallogr Sect E Struct Rep Online. 2010. PMID: 21587467 Free PMC article.

8

A Hexameric Ruthenium(III)-Containing Tungstoantimonate with Good Proton Conductivity Performance.

Sun Y, Li H, Zou Y, Ma P, Niu J, Wang J. Sun Y, et al. Among authors: li h. Inorg Chem. 2023 Sep 4;62(35):14142-14146. doi: 10.1021/acs.inorgchem.3c01342. Epub 2023 Aug 21. Inorg Chem. 2023. PMID: 37603397

9

Robust Heterostructures in Two-Dimensional Perovskites by Threshold-Dominating Anion Exchange.

He C, Li J, Bao Y, Li J, Wang H, Zhang M, Li H, Tang H, Sun Z, Zhang Q, Fang Y, Xu J, Yang Y. He C, et al. Among authors: li h. Small. 2022 Aug;18(31):e2203036. doi: 10.1002/smll.202203036. Epub 2022 Jul 7. Small. 2022. PMID: 35798317

10

Construction of Hexameric Ru-Substitution POMs to Improve Photocatalytic H₂ Evolution.

Chen W, Li H, Jin Y, Lei W, Bai Q, Ma P, Wang J, Niu J. Chen W, et al. Among authors: li h. Inorg Chem. 2023 Nov 6;62(44):18079-18086. doi: 10.1021/acs.inorgchem.3c02220. Epub 2023 Oct 25. Inorg Chem. 2023. PMID: 37877470

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Results by year